Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Asset Utilization Ratio (2020 - 2025)

Foghorn Therapeutics (FHTX) has 6 years of Asset Utilization Ratio data on record, last reported at 0.15 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 100.98% year-over-year to 0.15; the TTM value through Dec 2025 reached 0.15, up 100.98%, while the annual FY2025 figure was 0.13, 61.66% up from the prior year.
  • Asset Utilization Ratio reached 0.15 in Q4 2025 per FHTX's latest filing, up from 0.11 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.15 in Q4 2025 and bottomed at 0.0 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.07, with a median of 0.07 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: soared 1126.68% in 2022, then tumbled 33.04% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then skyrocketed by 1126.68% to 0.05 in 2022, then surged by 148.61% to 0.11 in 2023, then plummeted by 33.04% to 0.08 in 2024, then skyrocketed by 100.98% to 0.15 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.15 in Q4 2025, 0.11 in Q3 2025, and 0.1 in Q2 2025.